Showing 1221-1230 of 18571 results for "".
Multiple Sclerosis Explained: Understanding Its Epidemiology
https://reachmd.com/programs/neurofrontiers/multiple-sclerosis-explained-understanding-its-epidemiology/32371/Hear about how multiple sclerosis impacts patients, and learn about genetic and environmental factors associated with the onset of the disease.Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
https://reachmd.com/programs/advances-in-womens-health/hormonal-iuds-perimenopause/48740/Following years of caution surrounding hormone therapy, new guidance and updates have renewed interest in estrogen use for perimenopausal patients. Hormonal intrauterine devices (IUDs) in particular are emerging as a valuable option for supporting endometrial health. Tune in to hear Dr. Mary KatheriInnovation in Androgenetic Alopecia
https://practicaldermatology.com/series/dermwire-tv/innovation-in-androgenetic-alopecia/54611/Diana Harbort, President of Cosmo Pharmaceuticals' Dermatology Division, discusses the need for new innovations in androgenetic alopecia and the promise of clascoterone for treating the condition.Inside the COVID-19 Response: Scientific Rigor Amid Uncertainty
https://reachmd.com/programs/clinicians-roundtable/covid-19-response-scientific-rigor/48835/During the COVID-19 pandemic, healthcare leaders navigated a turbulent scientific landscape while upholding a consistent, evidence-based process for decision-making. Dr. Jason Goldman, the President of the American College of Physicians as well as their liaison to the CDC Advisory Committee on ImmunHow Daily Light Habits Influence Migraine in Adolescents
https://reachmd.com/programs/frontlines-migraine/daily-light-habits-migraine-adolescents/48940/Light exposure plays a crucial role in circadian regulation, but for young people with migraines, it can also trigger discomfort and avoidance behaviors. As a result, a recent study examined adolescent light exposure patterns and their potential connection to increased headache frequency and disruptDiagnosing and Treating Hemochromatosis: Expert Insights
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-hemochromatosis-expert-insights/39214/Hemochromatosis, a genetic condition that causes the body to absorb too much iron from food, often goes unrecognized despite its prevalance. With unique diagnostic and management challenges, it's crucial to understand how it presents, which testing strategies are most effective, and what treatment oManaging Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
https://reachmd.com/programs/heart-matters/managing-statin-intolerance-practical-approaches-and-emerging-non-statin-options/37858/Statin intolerance, though uncommon, presents a challenge for patients who experience persistent side effects despite adjustments in dosing or switching statins. Dr. Matthew Sorrentino reviews evidence-baesd alternatives, shares insights on practical use in clinical care, and highlights the latest aTreatment Revolution in IgA Nephropathy
https://reachmd.com/programs/kdigo-conversations-nephrology/treatment-revolution-in-iga-nephropathy/37116/Treatment Revolution in IgA NephropathyExploring Technological Advances in GI Training: Practical Insights for Clinicians
https://reachmd.com/programs/gi-insights/exploring-technological-advances-in-gi-training-practical-insights-for-clinicians/32875/Artificial intelligence, simulation platforms, augmented reality, and other technological innovations are transforming our approach to GI training. In this expert-led discussion, Dr. Peter Buch sits down with Dr. Nabil Mansour to discuss how we can integrate cutting-edge tools into colonoscopy trainAre Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
https://reachmd.com/programs/project-oncology/are-subcutaneous-immunotherapies-expanding-access-and-efficiency-in-cancer-care/36401/Subcutaneous immunotherapies are emerging as a promising alternative to traditional IV delivery for immune checkpoint inhibitors, demonstrating comparable safety and efficacy along with meaningful time savings. But reimbursement gaps, dosing complexities, and biosimilar competition present challenge